The survival analysis indicated that a high expression level of ARPC1B was associated with poorer overall survival and progression-free survival in ovarian cancer patients (Figures 1B–D), suggesting the prognostic significance of ARPC1B. Here, ARPC1B is linked to ovarian cancer.